Left ventricular geometric patterns in normotensive type 2 diabetic patients in nigeria: An echocardiographic study

Preventive Cardiology

Volumn 12, Issue 4, 2009, Pages 184-188

  Ojji, Dike B ^a   Adebiyi, Adewole A ^a   Oladapo, Olulola O ^a   Adeleye, Jokotade A ^a   Aje, Akinyemi ^a   Ogah, Okechukwu S ^a   Adebayo, Adedeji K ^a   Falase, Ayodele O ^a  

^a UNIVERSITY OF ABUJA   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET THERAPY; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MULTIPLE LINEAR REGRESSION ANALYSIS; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NIGERIA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 70350116166     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2009.00033.x     Document Type: Article

References (31)

1. Rubler S, Dlugash J, Yuceoglu YZ. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595-602.
2. Ashmed SS, Jaferi GA, Narang RM. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J 1975, 89:153-158.
3. Grossman E, Shemesh J, Shamiss A. Left ventricular mass in diabetes-hypertension. Arch Intern Med 1992, 152:1001-1004.
4. Devereux RB, Roman MJ, Paranicas M. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000, 101:2271-2276.
5. Ilercil A, Devereux RB, Roman MJ. Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am Heart J 2001, 141:992-99.
6. Rotimi CN, Cooper RS, Okosun IS. Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans and US blacks. Ethn Dis 1999, 9(2):190-194.
7. Kadiri S, Salako BL. Cardiovascular risk factors in middle-aged Nigerians. East Afr Med J 1997, 74(5):303-306.
8. Rotimi O, Fatusi AO, Odesanmi WO. Sudden cardiac death in Nigerians-Ile-Ife experience. West Afr J Med 2004, 23(1):27-31.
9. Adedeji OO. Diet, alcohol consumption, smoking and exercise as determinants of blood lipid levels of Nigerians. West Afr J Med 2000, 19(4):283-285.
10. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
11. Du Bois D, Du Bois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916, 17:863-867.
12. Sahn DJ, DeMaria A, Kisslo J. Recommendation regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978, 56:1072-1083.
13. Teicholz LE, Kreulen T, Herman MV. Problems in echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976, 37:7-11.
14. Devereux RB, Alonso DR, Lutas EM. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
15. Ogah OS, Adebiyi AA, Oladapo OO. Association between electrocardiographic left ventricular hypertrophy with strain pattern and left ventricular structure and function. BMC 2006, 20:6.
16. Palmieri V, Bella JN, Arnett DK. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Circulation 2001, 103:102-107.
17. Picca M, Agozzino F, Pelosi G. Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus. Ital Heart J 2003, 4:48-52.
18. Wachtell K, Palmieri V, Oslen MH. Urine albumnin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002, 143:319-326.
19. Fisher VW, Barner HB, Leskiw ML. Capillary basal laminar thickness in diabetic human myocardium. Diabetes 1979, 28:713-719.
20. Galderisi M, Anderson KM, Wilson PWF. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol 1991, 68:85-89.
21. Rodrigues B, Cam MC, McNeil JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998, 180:53-57.
22. Iozzo P, Chareonthaitawee P, Rimoldi O. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with type 2 diabetes. Diabetologica 2002, 45:1404-1409.
23. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002, 105:1861-1870.
24. Roman MJ, Pickering TG, Schwartz JE. Association of carotid atherosclerosis and left ventricular hypertrophy. JACC 1995, 25(1):83-90.
25. Schirmer H, Lund P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population; The Tromso Study. Eur Heart J 1999, 20(6):429-438.
26. Skeleton TN, Andrew ME, Arnett DK. Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study. Echocardiography 2003, 20:111-120.
27. De Simone G, Palmieri V, Bella JN. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 2002, 20:323-331.
28. Kizer JR, Arnett DK, Bella JN. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension 2004, 43:1182-1188.
29. Levy D, Garrison RJ, Savage DD. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
30. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. JACC 1995, 25(4):879-884.
31. Roman MJ. How best to identify prognostically important left ventricular hypertrophy. JACC 1997, 29:648-650.